Get the Stockscreener App
368.14
0.38%
-1.42
Pre-market:
367.13
-1.01
-0.27%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $368.14, with a volume of 1.82M.
It is down -0.38% in the last 24 hours and up +5.73% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$369.56
Open:
$367.93
24h Volume:
1.82M
Relative Volume:
1.03
Market Cap:
$140.79B
Revenue:
$25.12B
Net Income/Loss:
$3.25B
P/E Ratio:
43.82
EPS:
8.4018
Net Cash Flow:
$4.28B
1W Performance:
+3.13%
1M Performance:
+5.73%
6M Performance:
-2.55%
1Y Performance:
-5.92%
1-Day Range:
$363.92
$369.61
1-Week Range:
$350.32
$375.92
52-Week Range:
$329.16
$404.14
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
368.14 | 141.33B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
ABT
Abbott Laboratories
|
109.41 | 190.06B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
91.87 | 138.71B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
102.71 | 132.00B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
82.65 | 47.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker Corporation $SYK Shares Sold by Mediolanum International Funds Ltd - MarketBeat
[Latest] Global Advanced Wound Closure Market Size/Share Worth USD 32.54 Billion by 2035 at a 6.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Stryker Corporation (NYSE:SYK) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Stryker (SYK) Earnings Call Highlights Growth and Resilience - TipRanks
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $387 to $465 - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Regeneron (REGN) and NewAmsterdam Pharma Company (NAMS) - The Globe and Mail
Stryker Corporation (NYSE:SYK) Q4 2025 Earnings Call Transcript - Insider Monkey
Stryker raises annual profit forecast on strong sales for medical devices - Reuters
Assessing Stryker (SYK) Valuation After Strong Results And Optimistic 2026 Growth Outlook - Yahoo Finance
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $412 to $454 - 富途牛牛
Piper Sandler Maintains Overweight Rating on Stryker Corporation (SYK) - Finviz
Stryker starts first cases with handheld ortho robot - MedTech Dive
Stryker (NYSE:SYK) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
Stryker stock price target raised to $412 from $410 at BTIG By Investing.com - Investing.com South Africa
Evercore ISI Adjusts Stryker Price Target to $400 From $390, Maintains Outperform Rating - marketscreener.com
BTIG Research Adjusts Stryker Price Target to $412 From $410, Maintains Buy Rating - marketscreener.com
Needham raises Stryker stock price target to $454 on strong Q4 results By Investing.com - Investing.com South Africa
Barclays Adjusts Stryker Price Target to $469 From $462, Maintains Overweight Rating - marketscreener.com
Stryker (NYSE:SYK) Given New $454.00 Price Target at Needham & Company LLC - MarketBeat
Needham raises Stryker stock price target to $454 on strong Q4 results - Investing.com
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target By Investing.com - Investing.com India
Stryker (NYSE:SYK) Issues FY 2026 Earnings Guidance - MarketBeat
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target - Investing.com
Stryker rises after raising annual profit forecast - TradingView
Stryker enters 2026 with ‘strong momentum’ after FY25 revenue eclipses $25bn - Yahoo Finance
Knights of Columbus Asset Advisors LLC Has $8.95 Million Holdings in Stryker Corporation $SYK - MarketBeat
Stryker price target raised to $412 from $410 at BTIG - TipRanks
Pittenger & Anderson Inc. Acquires 11,827 Shares of Stryker Corporation $SYK - MarketBeat
Tandem Investment Advisors Inc. Acquires 7,425 Shares of Stryker Corporation $SYK - MarketBeat
The Analyst Verdict: Stryker In The Eyes Of 11 Experts - Benzinga
Stryker stock rating reiterated at Market Outperform by Citizens - Investing.com
Stryker (SYK) Receives Price Target Increase from Needham | SYK Stock News - GuruFocus
Stryker Corporation $SYK Shares Bought by Mirae Asset Global Investments Co. Ltd. - MarketBeat
BTIG Raises Price Target for Stryker (SYK) to $412 Following Ana - GuruFocus
Stryker stock price target raised to $412 from $410 at BTIG - Investing.com
Benedict Financial Advisors Inc. Makes New Investment in Stryker Corporation $SYK - MarketBeat
Federated Hermes Inc. Grows Position in Stryker Corporation $SYK - MarketBeat
Stryker Q4 Earnings Call Highlights - Yahoo Finance
Stryker’s 2025 Q4 earnings exceed Wall Street predictions - MassDevice
Stryker Reports Strong Q4 2025 Earnings with Record Growth - Intellectia AI
Stryker (SYK) Reports Strong Q4 2025 Earnings, Projects Growth i - GuruFocus
Stryker Corp (SYK) Q4 2025 Earnings Call Highlights: Record Revenue and Robust Growth Amid ... - Yahoo Finance
Stryker raises annual profit forecast on strong sales for medical devices By Reuters - Investing.com
Stryker Corp (NYSE:SYK) Beats Q4 EPS Estimates, Provides 2026 Guidance - Chartmill
Earnings call transcript: Stryker Q4 2025 earnings beat forecasts, stock dips - Investing.com
Stryker (SYK) Surges with Strong Q4 Results and Positive 2026 Ou - GuruFocus
Compared to Estimates, Stryker (SYK) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Stryker Q4 results beat on both lines; 2026 EPS guidance includes consensus - MSN
Stryker (SYK) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
Stryker (SYK) Achieves Impressive Revenue in Q4, Exceeds Expecta - GuruFocus
Stryker (SYK) Exceeds Q4 Expectations with Strong Earnings and R - GuruFocus
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):